Hong Ki Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Hong Ki Song has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jong Seok Bae
Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
3 shared publications Jinhyuk Yoo
2 shared publications- Yerim Kim
Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
2 shared publications Chae Young Lee
1 shared publication- Dae Won Kim
Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea
1 shared publication Donggook Kang
1 shared publication
Latest Publications
- Open Access
- 27 September 2018
- Published by Korean Neurocritical Care Society in Journal of Neurocritical Care
- Vol. 11 (2) , 129-133
Acute Ischemic Stroke in Moyamoya Syndrome Associated with Thyrotoxicosis
- 27 September 2018
- Published by Korean Neurocritical Care Society in Journal of Neurocritical Care
- Vol. 11 (2) , 129-133
Open AccessAcute Ischemic Stroke in Moyamoya Syndrome Associated with Thyrotoxicosis
- Open Access
- 30 June 2018
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 10 (1) , 34-36
Delayed Hypoglycemic Encephalopathy after Sleeve Gastrectomy
- 30 June 2018
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 10 (1) , 34-36
Open AccessDelayed Hypoglycemic Encephalopathy after Sleeve Gastrectomy
- Open Access
- 24 December 2015
- Published by Korean Neurocritical Care Society in Journal of Neurocritical Care
- Vol. 8 (2) , 118-121
Mild Encephalitis with a Reversible Splenial Lesion (MERS) Accompanied by Myelitis: A Case Report
- 24 December 2015
- Published by Korean Neurocritical Care Society in Journal of Neurocritical Care
- Vol. 8 (2) , 118-121
Open AccessMild Encephalitis with a Reversible Splenial Lesion (MERS) Accompanied by Myelitis: A Case Report
- Open Access
- 1 January 2013
- Published by Korean Neurotraumatology Society in Korean Journal of Neurotrauma
- Vol. 9 (2) , 36-40
Post-Traumatic Ictogenesis and Epileptogenesis
Song HK. Korean J Neurotrauma. 2013 Oct;9(2):36-40. http://dx.doi.org/10.13004/kjnt.2013.9.2.36
- 1 January 2013
- Published by Korean Neurotraumatology Society in Korean Journal of Neurotrauma
- Vol. 9 (2) , 36-40
Open AccessPost-Traumatic Ictogenesis and Epileptogenesis
Song HK. Korean J Neurotrauma. 2013 Oct;9(2):36-40. http://dx.doi.org/10.13004/kjnt.2013.9.2.36
- Open Access
- 28 October 2010
- Published by Springer Nature in BMC Neuroscience
- Vol. 11 (1) , 141
Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models
Background: In order to confirm the roles of creatine (Cr) in epilepsy, we investigated the anti-convulsive effects of Cr, creatine transporter (CRT) and creatine kinases (CKs) against chemical-induced acute seizure activity and chronic epileptic seizure activity. Results: Two hr after pilocarpine (PILO)-seizure induction, ubiquitous mitochondrial CK (uMtCK) immunoreactivity was unaltered as compared to control level. However, brain-type cytoplasm CK (BCK) immunoreactivity was decreased to 70% of control level. CRT immunoreactivity was decreased to 60% of control level. Following Cr or Tat-CK treatment, uMtCK or CRT immunoreactivity was unaffected, while BCK immunoreactivity in Cr treated group was increased to 3.6-fold of control levels. β-Guanidinopropionic acid (GPA, a competitive CRT inhibitor) reduced BCK and CRT expression. In addition, Cr and tat-BCK treatment delayed the beginning of seizure activity after PILO injection. However, GPA treatment induced spontaneous seizure activity without PILO treatment. In chronic epilepsy rats, both uMtCK and CRT immunoreactivities were reduced in the hippocampus. In contrast, BCK immunoreactivity was similar to that observed in control animals. Cr-, GPA and tat-BCK treatment could not change EEG. Conclusion: Cr/CK circuit may play an important role in sustaining or exacerbating acute seizure activity, but not chronic epileptic discharge.
- 28 October 2010
- Published by Springer Nature in BMC Neuroscience
- Vol. 11 (1) , 141
Open AccessEffects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models
Background: In order to confirm the roles of creatine (Cr) in epilepsy, we investigated the anti-convulsive effects of Cr, creatine transporter (CRT) and creatine kinases (CKs) against chemical-induced acute seizure activity and chronic epileptic seizure activity. Results: Two hr after pilocarpine (PILO)-seizure induction, ubiquitous mitochondrial CK (uMtCK) immunoreactivity was unaltered as compared to control level. However, brain-type cytoplasm CK (BCK) immunoreactivity was decreased to 70% of control level. CRT immunoreactivity was decreased to 60% of control level. Following Cr or Tat-CK treatment, uMtCK or CRT immunoreactivity was unaffected, while BCK immunoreactivity in Cr treated group was increased to 3.6-fold of control levels. β-Guanidinopropionic acid (GPA, a competitive CRT inhibitor) reduced BCK and CRT expression. In addition, Cr and tat-BCK treatment delayed the beginning of seizure activity after PILO injection. However, GPA treatment induced spontaneous seizure activity without PILO treatment. In chronic epilepsy rats, both uMtCK and CRT immunoreactivities were reduced in the hippocampus. In contrast, BCK immunoreactivity was similar to that observed in control animals. Cr-, GPA and tat-BCK treatment could not change EEG. Conclusion: Cr/CK circuit may play an important role in sustaining or exacerbating acute seizure activity, but not chronic epileptic discharge.
- 1 March 2005
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 25 (1) , 52-53
One-and-a-Half Syndrome With Facial Diplegia: The 15 1/2 Syndrome?
- 1 March 2005
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 25 (1) , 52-53
One-and-a-Half Syndrome With Facial Diplegia: The 15 1/2 Syndrome?